Placental pathology and neonatal encephalopathy
Neonatal encephalopathy (NE) is an important cause of neonatal morbidity and mortality worldwide; however, there remain gaps in our knowledge about its pathogenesis. The placenta has been implicated in the pathogenesis of this disease but conclusive evidence related to the placental factors that influence it is sparse. This review aims to outline the current knowledge on the role of the placenta with particular attention to its role in NE as a consequence of hypoxia-ischemia. A total of 26 original articles/review papers were used to compile this review. Three themes were identified from these publications: fetal vascular malperfusion including umbilical cord pathology, inflammatory changes in the placenta, and maternal vascular malperfusion including placental weight. These features were identified as being significant in the development of NE. Advancing our understanding of this relationship between placental pathology and NE may facilitate the development of additional antenatal screening to better identify at-risk fetuses. We highlight areas for further research through antenatal screening and placental histology.
Funding
Open access funding provided by IReL
History
Data Availability Statement
Data sharing is not applicable to this article as no new data were created or analyzed in this studyComments
The original article is available at https://obgyn.onlinelibrary.wiley.com/Published Citation
Fox A, Doyle E, Geary M, Hayes B. Placental pathology and neonatal encephalopathy. Int J Gynaecol Obstet. 2022;160(1):22-27Publication Date
13 June 2022External DOI
PubMed ID
35694848Department/Unit
- Obstetrics and Gynaecology
Publisher
John Wiley & Sons, IncVersion
- Published Version (Version of Record)